Clinical trial reportFrontiers in immunologyPublished
Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Frontiers in immunology
- Published
- Topic
- Public health
- Subject terms
- Humans; Multiple Myeloma; Thalidomide; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Treatment Outcome; Immunotherapy, Adoptive; Drug Resistance, Neoplasm; Aged; Middle Aged; Cost-Benefit Analysis
- PubMed ID
- 39234256
- PubMed Central ID
- PMC11372240
- Open access
- Yes, open
- Added to directory
- Source checked